Drug price transparency (DPT) laws have been in effect in several states for a ...
Similar to the drug industry’s paradigm for Breakthrough Therapy Designation, the device industry’s opportunity ...
When developing content for new drug labels, life sciences companies’ regulatory teams face challenges ...
If the regulatory, policy, and political temper tantrums over the FDA’s approval of Exondys ...
While digital therapeutics (DTx) companies are extremely optimistic about the promise of software-based interventions ...
The 2018 Farm Bill redefined the meaning of hemp, opening the door to small ...
Today, developers of innovative medical devices are increasingly utilizing artificial intelligence (AI) and machine ...
Nearly 40% of all the over-the-counter medications in the U.S. were initially marketed as ...
Thanks to the exponential growth of the internet and the rapid take-up of technological ...
During the clinical development of pharmaceuticals, it is not uncommon for a program to ...
How are you approaching audience engagement at your organization? Perhaps you’re putting an emphasis ...
The concept of patient centricity is hardly new, but in recent months it has ...
On April 16, 2021, the FDA announced the withdrawal of their January 15, 2021 ...